Veterinary Oxygen Therapy Market - By Product, By Animal Type, By Application, By End Use - Global Forecast 2025 - 2034

Veterinary Oxygen Therapy Market Size

The global veterinary oxygen therapy market was valued at USD 1.2 billion in 2024. The market size is estimated to grow from USD 1.3 billion in 2025 to USD 2.7 billion in 2034, growing at a CAGR of 8.5% from 2025 to 2034. This growth is primarily attributed to the growing incidence of diseases such as pneumonia and chronic obstructive pulmonary disease (COPD) in animals, coupled with post-surgical recovery complications, which have significantly increased the demand for oxygen therapy in veterinary care.
 

The needs of older pets, along with problems related to pollution, obesity, and other related respiratory issues, further increase this need. Veterinary clinics and hospitals are using oxygen concentrators, high-efficiency masks, and nasal catheters to improve treatment results for these conditions.
 

Technological advancements is one of the factors contributing to the expansion of the veterinary oxygen therapy market by improving efficiency, portability, and treatment outcomes. The introduction of new portable oxygen concentrators helps in giving continuous oxygen, allowing veterinarians to treat animals at home and reducing the need for hospitalization. Additionally, the advancement of high-efficiency oxygen masks, humidifiers, and nasal catheters have improved patient comfort and oxygen absorption, especially in critical care and after surgery, leading to more demand for veterinary oxygen concentrators and related equipment.
 

Furthermore, increasing rates of pet ownership have also served as an important driver for the market. For instance, according to Health for Animals in 2022, the global pet population was more than one billion. Additionally, in the U.S., around 66% of households have pets, as reported by the American Pet Products Association (2023-2024), which has increased the need for basic veterinary services and emergency treatments, including oxygen therapy that needs concentrators and other equipment.
 

Also, pet insurance has helped market growth by making advanced medical treatments, like oxygen therapy, easier to afford and access. The growth of veterinary emergency and critical care services has also helped the market grow. Many veterinary hospitals now offer 24-hour oxygen therapy support, which helps more pets survive when they have breathing problems, injuries, or problems after surgery. This increased availability has created more demand for oxygen concentrators, masks, humidifiers, and nasal catheters.
 

The market includes special medical equipment made to give extra oxygen to animals. It is majorly used for animals suffering from respiratory distress, hypoxia (low blood oxygen levels), or other conditions requiring oxygen support. Oxygen concentrators and accessories are commonly used in veterinary clinics, hospitals, and emergency settings.
 

Veterinary Oxygen Therapy Market Trends

• The increasing number of pets and rising expenditure on veterinary care is driving the growth of market. For instance, according to 2024 APPA National Pet Owner's Survey shows that 82 million households in the U.S. have pets.
   
• As the pet population increases, there is an increased focus on providing high-quality healthcare to them, which has resulted in increased demand for advanced treatments, including oxygen therapy for respiratory conditions, post-surgical recovery, and emergency care.
   
• Additionally, the increasing expenditure on pet healthcare is an essential contributor to the growth of this market. As per the estimates of the American Pet Products Association (APPA), USD 147 billion were spent on pets in the U.S. in 2023. Notably, USD 38.3 billion was spent on veterinary services and pet products which indicates that pet owners are willing to spend more on specialized medical care. 
   
• Further, the high adoption of pet insurance makes pet owners more willing to allow more advanced veterinary procedures such as oxygen therapy for pneumonia, respiratory distress, and post-operative recovery which utilizes oxygen concentrators and other accessories.
   
• There is an increase in the expenditure on veterinary care as pets are increasingly being viewed as family members. This humanization of pets has resulted in an increased focus on preventive and emergency medical treatments, requiring technologically advanced equipment like oxygen concentrators for the management of respiratory distress, postoperative care, alongside emergency medicine, thus positively driving the market growth.
   

Veterinary Oxygen Therapy Market Analysis

Based on the product, the global veterinary oxygen therapy market is segmented into veterinary oxygen concentrator and accessories. The veterinary oxygen concentrator segment dominated the market and was valued at USD 984.5 million in 2024. The veterinary oxygen concentrator segment is further sub-segmented into stationary oxygen concentrator and portable oxygen concentrator.
 

• The increasing number of veterinary surgical procedures and emergency cases that need oxygen therapy contributes to the growth of this segment. The need for oxygen concentrators has increased due to health problems like respiratory distress syndrome, pneumonia, bronchitis, and other related issues in aging pets.
   
• Oxygen concentrators are more efficient and cost-effective than traditional oxygen cylinders, which need to be refilled frequently and require costly maintenance. This has greatly enabled the segment's growth as more veterinary professionals can rely on sustainable and easily accessible oxygen resources.
   
• Improved working in veterinary medicine practices due to the use of advanced portable, lightweight, and energy-efficient concentrators facilitates both clinical and mobile veterinary services. Thus, making them ideal particularly in remote locations for treating farm animals and pets where traditional oxygen delivery methods may not be easily accessible.

Based on animal type, the global veterinary oxygen therapy market is categorized into small animals and large animals. The small animals segment held the highest market share of 60% in 2024.
 

• The growth of this segment is driven by the substantial global population of these pets. For instance, as per World Population Review, as of 2024, approximately 30% of households globally have a dog, totaling between 700 million to 1 billion dogs. The U.S. alone has around 90 million dogs. Also, there are an estimated 600 million cats worldwide. Of these 600 million, around 220 million are house cats kept as pets, and 480 million are stray or feral cats. Such high volume of small animals increases the segmental growth.
   
• Another significant factor contributing to the high share is the high incidence of respiratory problems in small animals, especially brachycephalic ones such as pugs, bulldogs, and Persian cats. These breeds have to use oxygen therapy quite often.
   
• Additionally, increasing prevalence of conditions such as pneumonia, heart failure, and post-surgical complications drives the demand for oxygen support, further driving the demand for veterinary oxygen therapy.
   

Based on the application, the global veterinary oxygen therapy market is classified into intensive care, homecare setting/ postoperative care, and other applications. The intensive care segment is expected to witness growth at 8.4% CAGR over the analysis period and reach USD 1.8 billion by 2034.
 

• The rising incidence of severe illnesses and emergencies in both companion and livestock animals has created a need for advanced intensive care treatments, such as oxygen therapy. Conditions like respiratory distress, heart diseases, post-surgical complications, and trauma cases have resulted in a greater demand for specialized oxygen therapy solutions within veterinary practices.
   
• As a result, veterinary clinics and hospitals are making significant investments in intensive care units (ICUs) that include high-quality oxygen delivery systems, which is contributing to market growth.
   
• Additionally, the increase in pet ownership and expenditure on veterinary healthcare has played a crucial role in boosting demand for intensive care services. As pets are increasingly seen as family members, owners are more willing to choose advanced treatment options to ensure their animals' health and well-being, further supporting market expansion.
   

Based on the end use, the global veterinary oxygen therapy market is divided into veterinary hospitals, veterinary clinics, and other end users. The veterinary hospitals segment in 2024 was valued at USD 568.6 million and is expected to reach USD 1.3 billion by the end of the forecast timeframe.
 

• The expansion is propelled by the rising demand for advanced pet healthcare and the greater number of specialized veterinary facilities. Due to the advanced technology, veterinary hospitals have ICUs with emergency response teams and specialized units for oxygen therapy. These facilities have become the primary centers for the treatment of critical conditions like respiratory distress, trauma, and post-surgical complications.
   
• Another key factor contributing to this growth is an increase in spending on pet healthcare, adoption of new medical technologies, and expanding number veterinary hospitals.
   
• Furthermore, more pet owners are prioritizing specialized treatments, and the growing availability of pet insurance has made costly oxygen therapy treatments more accessible, thereby boosting the market growth.

The North America veterinary oxygen therapy market dominated the global market with a market share of 39.9% in 2024.
 

The U.S. market was valued at USD 364.9 million in 2021. In 2023, the U.S. dominated the North America market with a revenue of USD 413 million growing from USD 387.9 million in 2022.
 

• One of the driving forces behind this growth is the marked increase in spending related to pets. The American Pet Products Association reported that spending on pets was USD 152 billion in 2024 and is expected to grow to USD 157 billion in 2025, signifying the increasing pet owner expenditure on sophisticated treatments including oxygen therapy.
   
• This surge in spending is fueled by heightened awareness, increased spending awareness, enhanced access to veterinary hospitals, and the availability of dedicated treatment for breathing and heart problems, as well as post-operative care.
   
• The incorporation of advanced critical care services such as oxygen therapy into U.S. veterinary hospitals and specialty clinics is another significant development in the market.
   
• The growing number of pets diagnosed with chronic airway diseases has further propelled the demand for veterinary oxygen therapy solutions.
   

Germany veterinary oxygen therapy market is anticipated to witness considerable growth in the Europe market over the analysis period.
 

• According to the Central Association of Zoological Specialist Companies (ZZF), German households maintained approximately 34.3 million pets in 2023, including dogs, cats, small mammals, and birds. This large pet population has increased the demand for veterinary services, especially advanced treatments like oxygen therapy.
   
• The growth of specialized veterinary clinics and increasing awareness about pet health have further expanded the oxygen therapy market in Germany.
   

India veterinary oxygen therapy market is anticipated to witness high growth in Asia Pacific market.
 

• In India, the trend of pet ownership in urban areas is growing, with people adopting dogs and cats as companions. This shift has increased the need for more specialized veterinary services, including oxygen therapy, managing respiratory problems, postoperative care, and emergency surgeries.
   
• Moreover, India's farm animal population such as cattle, poultry, and other livestock—is among the highest in the world. This large population requires improved veterinary care to manage their health and productivity.
   
• Another key factor contributing to this growth is the rapid expansion of veterinary clinics, pet hospitals, and specialty care centers across India.
   

In Latin America, Brazil veterinary oxygen therapy market is anticipated to experience significant growth in coming years.
 

• According to the Pet Food Industry, Brazil has around 160 million pets, ranking it third in the world after the U.S. and Japan, with 60 million dogs and 30 million cats. The number of households having at least one pet is 32 million.
   
• With the growing pet ownership, more Brazilians are spending on better healthcare services for their animals, which increases the demand for oxygen therapy in veterinary clinics and hospitals.
   
• The growing trend of treating pets as family members has led to higher spending on veterinary medicine such as respiratory treatments, post-operative care, and specialized intensive care monitoring.
   

In Middle East and Africa, Saudi Arabia veterinary oxygen therapy market is poised to witness rapid growth over the analysis period.
 

• Factors such as surging pet population, enhanced concern for animal welfare, and government policies aimed at improving veterinary care infrastructure are driving the market growth.
   
• Saudi Arabia has an increasing network of veterinary clinics and hospitals, which along with improvements in veterinary critical care, is increasing the adoption of oxygen therapy devices.
   
• Furthermore, the increasing investments in new veterinary instruments, alongside the rising prevalence of respiratory diseases among companion and livestock animals, is accelerating market growth.
   

Veterinary Oxygen Therapy Market Share

The market is witnessing a surge in competition, as several major players focus on gaining additional market share through new technologies, partnerships, and geographical expansions. Top 5 players in this market including Vetland Medical, CAIRE, Longfian Scitech, RWD Life Science, and Drive DeVilbiss accounted for approximately 20 - 25% of market share. These players are focusing on higher spending on R&D to improve efficiency in oxygen delivery, as well as to miniaturize and enhance the portability of the equipment. In addition, strategic partnerships, acquisitions, and collaborations with veterinary clinics and hospitals are often employed to broaden market access.
 

Veterinary Oxygen Therapy Market Companies

Some of the prominent players operating in the veterinary oxygen therapy industry include:

• AEOLUS International Pet Products
• Airnetic
• BMV Animal Technology
• CAIRE
• Drive DeVilbiss International
• Imex Medical Limited
• Koninklijke Philips
• Longfian Scitech
• RWD Life Science
• Shinova Systems
• Vetland Medical
   

Renowned for high-quality oxygen therapy equipment, CAIRE provides reliable oxygen concentrators like the AirSep series, known for their efficiency and durability in both human and veterinary applications. The company's advanced oxygen solutions ensure consistent, high-purity oxygen delivery, supporting veterinary clinics, hospitals, and critical care units worldwide.
 

Shinova’s veterinary oxygen concentrators stand out for their durability, safety, and advanced technology. Designed with a full plastic shell for a sleek appearance, they feature built-in safety valves, power failure alarms, and high-purity oxygen delivery using USA-imported molecular sieves. Their CPU-controlled system with Motorola pressure sensors ensures precision, reliability, and seamless veterinary care.
 

Veterinary Oxygen Therapy Industry News

• In March 2025, BMV Animal Technology introduces cutting-edge respiratory solutions for pet hospitals with the launch of the BAM-5 Pro Turbo Ventilator and BAM-2 Oxygen Concentrator. This innovation strengthened the company's position in veterinary medical technology, enhancing its market reach and reputation.
   

The veterinary oxygen therapy market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Veterinary oxygen concentrator
  • Stationary oxygen concentrator
  • Portable oxygen concentrator
• Accessories   

Market, By Animal Type

• Small animals
• Large animals

Market, By Application

• Intensive care
• Homecare setting/postoperative care
• Other applications

Market, By End Use

• Veterinary hospitals
• Veterinary clinics
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE